NCT00184743

Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)

Investigation of the Efficacy and Safety of NN-220 for 48 Weeks in Adults With Growth Hormone Deficiency

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 112 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This trial is conducted in Japan. To investigate the long-term efficacy as assessed by change in fat mass and safety after 48 weeks of treatment of Growth Hormone in adults with Growth Hormone Deficiency, comparing two different treatment regiments.

Conditions

• Growth Hormone Disorder
• Adult Growth Hormone Deficiency

Interventions

Type	Name	Description
DRUG	somatropin

Timeline

• Start date: 2003-12-06
• Primary completion: 2005-12-28
• Completion: 2005-12-28
• First posted: 2005-09-16
• Last updated: 2017-02-28

Locations

1 site across 1 country: Japan